Budd-Chiari Syndrome Management: Controversies and Open Issues

Area of Science:

• Hepatology
• Vascular Medicine
• Internal Medicine

Background:

• Budd-Chiari Syndrome (BCS) is a rare condition characterized by hepatic vein (HV) or inferior vena cava (IVC) thrombosis.
• This obstruction leads to impaired hepatic venous outflow, causing portal hypertension and liver dysfunction.

Discussion:

• Understanding the pathophysiology of BCS is crucial for timely diagnosis and effective treatment strategies.
• The clinical presentation of BCS can be variable, ranging from acute to chronic, making diagnosis challenging.

Key Insights:

• Hepatic vein thrombosis is the primary cause of Budd-Chiari Syndrome.
• Impaired hepatic venous outflow is the direct consequence, leading to significant liver morbidity.

Outlook:

• Further research into genetic and acquired risk factors for thrombosis in BCS is warranted.
• Advancements in imaging and interventional radiology offer improved diagnostic and therapeutic options for BCS patients.